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Abstract
Background:  Little is known about genetic factors affecting intraocular pressure (IOP) in mice
and other mammals. The purpose of this study was to determine the IOPs of genetically distinct
mouse strains, assess the effects of factors such as age, sex and time of day on IOP in specific strain
backgrounds, and to assess the effects of specific candidate gene mutations on IOP.
Results:  Based on over 30 studied mouse strains, average IOP ranges from approximately 10 to
20 mmHg. Gender does not typically affect IOP and aging results in an IOP decrease in some strains.
Most tested strains exhibit a diurnal rhythm with IOP being the highest during the dark period of
the day. Homozygosity for a null allele of the carbonic anhydrase II gene (Car2 n) does not alter IOP
while homozygosity for a mutation in the leptin receptor gene (Lepr db) that causes obesity and
diabetes results in increased IOP. Albino C57BL/6J mice homozygous for a tyrosinase mutation (Tyr
c-2J) have higher IOPs than their pigmented counterparts.
Conclusions:  Genetically distinct mouse strains housed in the same environment have a broad
range of IOPs. These IOP differences are likely due to interstrain genetic differences that create a
powerful resource for studying the regulation of IOP. Age, time of day, obesity and diabetes have
effects on mouse IOP similar to those in humans and other species. Mutations in two of the
assessed candidate genes (Lepr and Tyr) result in increased IOP. These studies demonstrate that
mice are a practical and powerful experimental system to study the genetics of IOP regulation and
disease processes that raise IOP to harmful levels.
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Background
Glaucoma is a leading cause of blindness but its molecu-
lar etiology is poorly understood. Glaucoma involves ret-
inal ganglion cell death and optic nerve damage that is
often associated with elevated intraocular pressure (IOP)
[1–5].
It is becoming increasingly clear that many forms of
glaucoma have a genetic component [6,7], and much
current research is focused on identifying chromosomal
regions and genes that contribute to glaucoma [8–10].
Identifying such loci allows screening for individuals
with an increased risk of developing glaucoma [11]. Iden-
tifying genes contributing to elevated IOP and glaucoma
is only the first step, however, and animal models will
provide systems for subsequent hypothesis testing and
experimental dissection of pathogenesis.
Due to conservation in mammalian physiology and the
powerful tools of mouse genetics, mice are a very impor-
tant experimental system for probing the functions (both
in health and disease) of many genes recently identified
by sequencing the human genome [12]. We have focused
on developing the mouse system for IOP and glaucoma
studies [13–19]. Mice are expected to be extremely help-
ful in characterizing genes and mechanisms that affect
IOP or the susceptibility of the optic nerve and retina to
glaucomatous damage [20].
Very little is known about the magnitude of IOP of vari-
ous mouse strains or IOP fluctuation in mice with time or
other factors. Previously, we developed a method to
measure IOP in mice and reported initial findings on the
magnitude of mouse IOP [13]. The procedure involves
direct measurement of pressure following cannulation of
the anterior chamber. The initial experiments demon-
strated that in our hands careful ocular cannulation has
a very minor effect on IOP (average of -0.3 mmHg, mode
-0.5 mmHg) and demonstrated significant differences in
intraocular pressure levels between four mouse strains.
Here, we provide an update, including an extensive
strain survey, and show that the methodology is reliable
and produces reproducible data over extended periods of
time.
Results
A broad range of IOPs between strains
Figure 1 shows the average IOP of a number of inbred
mouse strains that were housed in the same environ-
mental conditions. There is a wide range of IOP with
strain BALB/cJ having one of the lowest average IOPs
(11.1 ± 0.5 mmHg) and strain CBA/CaJ one of the highest
IOPs (19.3 ± 0.3 mmHg). Significant differences exist
among various strains (P < 0.0001 for all groups, ANO-
VA comparing strains within each sex group).
Clinical and histological analysis of the eyes of all studied
strains (see Table 1) did not identify anatomic or patho-
logic features that might account for the differences in
IOP. For example, the iridocorneal angle and aqueous
humor drainage structures are open to the anterior
chamber and have normal morphology in both BALB/cJ
and CBA/CaJ mice (Figure 2). More than 20% of CBA/
CaJ mice had IOPs of over 21 mmHg, which increases
risk for glaucoma in humans. We aged a small group of
these mice (n = 4) to 2 years and histologically analyzed
their optic nerves and retinas but they did not develop
glaucoma.
Strain differences are reproducible
To assess the consistency of IOP in specific strains, we
measured IOP in different cohorts of each strain main-
tained under similar conditions at different times. We
purposefully included strains at each end of the IOP
spectrum, and strain C57BL/6J (B6) that is commonly
used for genetic experiments (Figure 3). The average IOP
of different cohorts of strains CBA/CaJ, CBA/CaHN
(both high end of spectrum) and B6 were consistent over
time. This was true of most strains assessed on multiple
occasions. Average IOP for age matched mice of the same
strain assessed at different times typically differed by no
more than 1.5 mmHg, and the differences were usually
smaller. Strain 129P3/J was the most variable strain
with the average IOP fluctuating by up to 2.5 mmHg.
Despite the general consistency of IOP, the average IOPs
of some strains have changed in a reproducible manner.
The IOPs of BALB/cJ mice (low end of spectrum) were
very similar for the past several years, around 11 mmHg.
Between early 1996 and 1997, however, the IOP of this
strain did jump from approximately 7.7 mmHg to ap-
proximately 11 mmHg (Figure 3). During this period, the
room in which our animals were housed and the manu-
facturer of the mouse diet were changed. Over the same
period, the IOP of A/J also increased dramatically, from
9.4 ± 0.5 mmHg (n = 11) in 1996 to 14.2 ± 0.4 mmHg (n
= 19) in 1997. The increased IOP in A/J also was repro-
ducible, with the average IOP of mice assessed in the year
2000 being 14.5 ± 0.4 mmHg (n = 16). Importantly, the
IOPs of strains B6 and C3H/HeJ did not change during
this time (B6, 12.3. ± 0.5 mmHg in 1996 and 12.4 ± 0.3
mmHg in 1997, n= 10 and 14; C3H/HeJ, 13.7 ± 0.8
mmHg in 1996 and 13.6 ± 0.2 mmHg in 1997, n = 9 and
19).
Effect of age on IOP
We focused on the commonly used B6, 129P3/J and
C3H/HeJ strains to determine the effects of age on IOP
(Figure 4). In B6, age had a significant effect on IOP (P <
0.001). IOP was slightly decreased at both 12 months
(12.2 ± 0.2 mmHg) and 19 months (12.2 ± 0.3 mmHg)BMC Genetics 2001, 2:12 http://www.biomedcentral.com/1471-2156/2/12
compared to 3 months (13.1 ± 0.3 mmHg) and 7 months
(13.3 ± 0.3 mmHg). Although the decrease was of a sim-
ilar level to the variation observed in 3 month old mice
(see Figure 3), the IOPs of control young mice (see Meth-
ods) analyzed at the same times as the various B6 age
groups did not decrease. For example, control mice ana-
lyzed at the same time as the 3 month, 12 month and 18
month B6 age groups had IOPs of 13.0 ± 0.2 mmHg (n =
14), 13.3 ± 0.2 mmHg (n = 14), 13.7 ± 0.4 mmHg (n = 12),
respectively. IOP was even lower in the 24 month B6
mice (10.8 ± 0.4 mmHg), and again the average IOP of
young controls measured at the same time was not
changed (13.5 ± 0.2, n = 12).
In strain 129P3/J, IOP did not differ significantly with
age between 3 and 14 months but was lower in 18 month
old mice (P < 0.001 compared to all younger ages, Figure
4). Despite a 1 mmHg dip in IOP at 8 months, there were
Figure 1
An almost two-fold range of IOP between genetically distinct mouse strains. Mean IOP ± SEM is shown for each
strain. Twelve to 25 mice were analyzed for each strain (typically 18 to 20), except for RIIIS/J (7 mice). Mice of most strains
were 6 to 12 months old, except for SEC/1ReJ and SB/Le that were 2 to 3 months old. Approximately half of the CE/J and one
third of the BUB/BnJ mice were 16 months old and were pooled with the younger mice, as the IOPs of both ages were the
same. Strain name CBA/CaHN-Btk xid/J is abbreviated to CBA/CaHN.
Figure 2
Normal iridocorneal angles in strains with high and low IOP. The iridocorneal angle that contains the aqueous humor
drainage structures (Schlemm's canal (SC) and trabecular meshwork (TM) had a normal morphology in strains CBA/CaJ (A,
high IOP), BALB/cJ (B, low IOP) and all other strains. Pigment filled macrophages that resemble human clump cells were often
located in the angle of CBA/CaJ mice but were never sufficient to block drainage. We have observed similar quantities of these
cells at this location in other strains with lower IOP. The angle recess between the cornea (C) and iris root (I) was open and
not occluded. Aqueous humor passes through this recess before entering the drainage structures. Original Magnification 630X.
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no significant IOP differences between C3H/HeJ mice at
each age tested (P = 0.2 for age). Although the effect of
age has not been thoroughly assessed in other strains, no
obvious age-related differences have been identified in
other strains analyzed at multiple ages except for the
glaucomatous DBA/2J and AKXD-28/Ty strains [14,19].
Effect of sex on IOP
Although we have not rigorously assessed the effect of
sex on IOP in many strains, sex specific differences have
not been detected in the majority of strains for which
both sexes have been analyzed, and have proven incon-
sistent even within an individual strain analyzed multi-
Table 1: Ocular abnormalities in various strains
Strain Clinical phenotype Mouse Eye Comments
incidence Incidence
SB/Le Oculocutaneous albinism with iris
transillumination
17/17 34/34 Chediak-Higashi syndrome caused by the beige mutation 
[80]
C57/LJ Iris transillumination 5/17 7/34 Incidence increased with age, iris atrophy sometimes evi-
dent at 20 months
BUB/BnJ Anterior subcapsular and cortical cataracts 2/8 2/16 Incidence in independent 3 to 4 month old mice was 9/12 
mice
17/24 eyes
AKR/J Irregular pupil 3/8 5/16
LP/J Cortical cataract 5/10 10/20
RIII/SJ Lens extrusion cataract 8/12 16/24
NZB/BiNJ Cortical cataract 7/14 10/28
All strains shown in Figure 1 were evaluated but only strains with abnormalities are shown. For incidence, the numerator indicates the number of 
mice or eyes affected and the denominator indicates the total number analyzed. The mice were 6 to 12 months old at the time of analysis and were 
not studied at other ages unless indicated. Histological analysis confirmed these observations and also identified calcified cyst like structures in the 
iris epithelium of strains SB/Le and SEC/1ReJ. A low incidence of corneal scarring was noted in some strains and likely resulted from a scratched 
cornea. Previously described retinal degeneration [81] caused by homozygosity for the Pde6b rd1mutation was noted in strains SB/Le, ST/bJ, BUB/
BnJ, CBA/J, C3H/HeJ, SJL/J and SWR/J.
Figure 3
The IOPs of different strains are stable and reproducible over time. Mean IOP ± SEM is shown for the indicated
strain at different times of measurement. The measurement times within a single year were separated by a few months. The
IOPs of strains that were analyzed multiple times in the same year are listed in the chronological order that they were obtained
with the earliest measurement on left. The sex [Male (M) or Female (F)], age (months), and number of mice (n) analyzed for
the CBA strains are listed starting with the earliest measurement and ending with the latest: CBA/CaJ, F, n = 22, age 6–7; M, n
= 11, age 2; CBA/CaHN, F, n = 16, age 3; M, n = 8, age 3. For BALB/cJ and C57BL/6J, all groups were male and primarily 3 to 4
months old. The number of mice analyzed at each time follows: BALB/cJ 8, 10, 11, 15, 18 and 14, C57BL/6J 10, 14, 21,40,40 and
42. Strain name CBA/CaHN-Btk xid/J is abbreviated to CBA/CaHN.
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ple times. Strains B6 and 129P3/J have been extensively
evaluated at multiple ages between 3 and 24 months of
age. Sex differences were always absent in strain 129P3/
J and typically absent in strain B6. In strain B6, however,
males infrequently had significantly higher IOP than fe-
males. For example, in one experiment, B6 males had an
average IOP of 14.2 ± 0.3 mmHg (n = 12) whereas the av-
erage IOP of females was 13.1 ± 0.3 mmHg (n = 12, P =
0.01). If real, this sporadic sex difference was not de-
pendent on age, sometimes occurring in a group of B6
mice at a particular age and sometimes not occurring in
a separate group of the same age.
Anesthesia protocol avoids IOP alteration and allows de-
tection of diurnal differences
All IOPs were assessed using an anesthetic regime of 99
mg/kg ketamine and 9 mg/kg xylazine (defined as 1X).
Initial experiments suggested that an almost identical
dose (100 mg/kg ketamine and 9 mg/kg xylazine) of an-
esthesia had no effect on IOP during the experimental
period with IOP being measured as soon as possible after
the mouse was unconscious, typically minutes. [13]. To
further assess the effects of anesthesia, we measured IOP
in groups of genetically identical B6 mice subjected to
different doses (1X, 1.5X and 2X) at 5 and 25 minutes af-
ter administration (Figure 5). For all doses, IOP de-
creased by 25 minutes (P = 0.005 for time). The greater
the dose the greater the decrease in IOP. At the 5 minute
measurement, however, IOP was the same using all dos-
es suggesting that the anesthetic effect on IOP had not
yet occurred. To identify any early window when it may
be possible to assess IOP without an obvious anesthetic
effect, 195 mice of strain B6 were anesthetized with the
1X dose and IOP was measured at 1 minute time points
between 4 and 12 minutes after administration (Figure
5). The mean IOP of groups analyzed at each time point
did not differ (P = 0.9) indicating that the IOP depressing
effect of anesthesia occurs later than 12 minutes after ad-
ministration. Similar results were obtained using 161
strain 129P3/J and 145 strain DBA/2J mice with the 1X
dose (129P3/J, P = 0.1; DBA/2J, P = 0.2). In support of
a later effect of anesthesia (since general anesthesia is re-
ported to mask diurnal variation in IOP [21]), we identi-
fied increased IOP during the dark compared to the light
period of the day in several tested strains (Figure 6). In
these experiments, IOP measurements were made be-
tween 5 and 12 minutes after administration of anesthe-
sia.
Blood pressure does not correlate with IOP
An initial study of the relationship between blood pres-
sure and IOP in mice did not detect a good correlation
(R2 = 0.1, Figure 7).
Myoc alleles do not associate with the magnitude of IOP
Mutations in the myocilin gene (MYOC) cause human
glaucoma. To determine if allelic variation in the mouse
Myoc gene associated with IOP in mouse strains, we an-
alyzed the gene in an assortment of strains with different
IOPs. Two alleles were identified. One of these alleles
had a 12 nucleotide insertion in the promoter region
(ccagagcagggt, between positions -340 and -341) com-
pared to the previously published sequence and is called
the insertion allele. The other allele was identical to the
published sequence [22]. The insertion allele also had a
previously reported substitution (A to G, Thr164Ala) in
exon 1 and several other single base changes in the pro-
moter region [22]. The presence or absence of this allele
does not associate with IOP as it is present in strains with
a range of IOPs (Figure 8).
Figure 4
IOP changes with increasing Age.  Mean IOP ± SEM is shown for the indicated strain at different ages. IOP decreased sig-
nificantly in strains C57BL/6J and 129P3/J but not C3H/HeJ. The C57BL/6J and 129P3/J groups consisted of approximately equal
numbers of males and females. The 3 months old C3H/HeJ mice were male while the other ages were composed of males and
females. The number of mice analyzed at each age, listed from youngest to oldest, follow: C57BL/6J, 18, 18, 18, 18, 13; 129P3/
J, 18, 15, 16, 14, 21; C3H/HeJ, 15, 23 17 and 16.
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Figure 5
No effect of 1X anesthetic dose within 12 minutes of administration.  A Mean IOP ± SD is shown for C57BL/6J mice
at 5 and 25 minutes after administration of various doses of anesthetic. The 1X dose consisted of 99 mg/kg ketamine and 9 mg/
kg xylazine. All doses decreased IOP by 25 minutes. At all doses the IOP at 5 minutes was the same suggesting that the effect
of anesthesia had not yet occurred. Approximately thirty 3 to 4 month old mice were analyzed at each dose and time B-D.
Scatter-plots demonstrating no change in IOP over the 12 minutes following anesthetic administration in three relatively unre-
lated mouse strains. All strains consisted of males and females that ranged from 3 to 6 months of age. The sexes and ages were
equally represented at each time point. The scatter-plots include 195 C57BL/6J, 161 129P3/J and 145 DBA/2J mice.
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Genetic alterations and IOP
Y Chromosome
The Y chromosome has been implicated in strain specific
blood pressure differences in rats [23,24]. To test if the Y
chromosome of strain 129/Ola alters IOP in relation to
that of strain B6, we compared the IOPs of pure B6 males
and consomic B6 males that had the 129P2/Ola Y chro-
mosome (backcrossed for 11 generations). No differences
in IOP were detected between these groups of mice (Fig-
ure 9, P = 0.1).
Car2
To test if deficiency of carbonic anhydrase II leads to de-
creased IOP, we analyzed mice of a B6 background that
were genetically similar but with normal or mutant alle-
les of the Car2 gene [25,26]. There was no difference in
IOP between normal and mutant mice (Figure 9, P =
0.5).
Lepr
To test if genetic perturbations that cause obesity and di-
abetes can alter IOP, we compared mice that were genet-
ically similar but were either homozygous or
heterozygous for a leptin receptor mutation (db) that re-
sults in obesity and diabetes before 4 months of age on
the C57BLKS/J strain background used [27]. IOP was
modestly but significantly elevated in obese, diabetic ho-
mozygous mutants (14.7 ± 0.3 mmHg) compared to non-
obese, non-diabetic heterozygotes (13.4 ± 0.4 mmHg, P <
0.01, Figure 9).
Tyr
To determine if albinism alters IOP, we analyzed B6 mice
that were either pigmented or albino. The albino mice
were homozygous and coisogenic for a mutant allele of
tyrosinase (Tyr  c-2J) that arose on the otherwise pig-
mented B6 background. In 2 month old mice, homozy-
gosity for Tyr c-2J resulted in increased IOP (14.2 ± 0.4
mmHg) compared to wild type, pigmented mice (12.4 ±
0.3 mmHg, P < 0.0001). The same was true for inde-
pendent cohorts of mice of different ages that were ana-
lyzed at different times (Figure 10A). In contrast to
pigmented B6 mice (Figure 6), the IOPs of the albino B6
mice were not increased at measurement during the dark
compared to light period of the day (P = 0.6, Figure 10B).
Discussion
IOP differences are reproducible and amenable to genetic 
analyses
We report the IOPs of over 30 genetically different
mouse strains that were housed in the same environ-
mental conditions. The magnitude of IOP differences be-
tween strains and the good reproducibility of readings
over time will allow the use of genetic approaches to
identify genes that underlie these differences. Using our
method, a trained investigator can measure the IOPs of
10 mice in an hour. Thus it is feasible to assess sufficient
Figure 6
IOP is increased during the dark compared to light periods in several strains.  Mean IOP ± SEM is shown for the
indicated strains at measurement during the light (open bars) or dark (filled bars) periods of the day. All mice were 2 to 4
months old except for CBA/CaJ that were 5 to 6 months old. 129B6 refers to mice of a mixed 129X1/SvJ and C57BL/6J back-
ground. IOP was increased during the dark in all strains except CBA/CaJ. The number of mice successfully analyzed during the
light (L) or dark (D) periods follows, DBA/2J 10L,10D; C57BL/6J 32L, 22D; C57BR/cdJ 12L,10D; SWR/J 16L, 16D; BALB/cByJ
15L, 16D; 129B6 10L, 12D; CBA/CaJ 22L, 16D.
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numbers of mice for quantitative trait locus (QTL) anal-
ysis methods and to use these methods to identify chro-
mosomal regions contributing to strain differences in
IOP. The strain survey we report provides valuable infor-
mation for designing these experiments. The throughput
and reproducibility also is sufficient for mutagenesis
screens [28–30]. These are important approaches as
they may allow the association of genes with IOP and
Figure 7
No correlation between blood pressure and IOP.  There is no strong correlation between the average systolic blood
pressure of each strain and the average IOP of that strain (R2 = 0.1). All mice were female and 2 to 4 months old, with the
exception that the female CBA/CaJ used for IOP assessment were 6 to 7 months old. If the CBA/CaJ mice are excluded, R2
drops to 0.01 of ARK/J, C57BL/6J and SJL/J, strain ARK/J had the lowest IOP.
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glaucoma whose currently known functions do not sug-
gest that they affect aqueous humor dynamics or do not
immediately identify them as likely glaucoma candi-
dates.
No effect of anesthetic protocol on IOP during a 12 minute 
measurement window
Many anesthetic agents including xylazine lower IOP.
Ketamine usually appears to increase IOP [31–33], but
there are reports of ketamine having no effect on IOP or
even reducing IOP [31,34]. Different doses, species used,
routes of administration or environments may contrib-
ute to these differences. The relationship between the
IOPs we measure and those in conscious mice depends
upon the effect of our anesthetic protocol (intraperito-
neal injection of 99 mg/kg ketamine and 9 mg/kg xyla-
zine). An anesthetic effect could potentially alter IOP and
mask genetically determined differences in IOP. There-
fore, it is very important to understand this effect. Here,
we show that, despite a depressant effect on IOP by 25
minutes, our anesthetic protocol has no detectable effect
on IOP during the first 12 minutes after administration.
Thus, to avoid effects of anesthesia on IOP, all measure-
ments should be made within a window of up to 12 min-
utes after anesthetic administration.
Similarities and differences to rat studies
Our results agree with the time course of cardiovascular
depression caused by intraperitoneal administration of
ketamine and xylazine in rats. In that study, anesthesia
had a minor effect on blood pressure during the first 15
minutes following injection but a strong hypotensive ef-
fect between 15 and 30 minutes that continued for more
than an hour [35]. In contrast, intraperitoneally admin-
istered ketamine (100 mg/kg) was shown to rapidly de-
crease IOP in a different rat study [36]. IOP decreased
significantly between a conscious measurement and the
first possible measurement under anesthesia (defined as
time 0). IOP decreased further by the next reading (at 5
minutes) after which it remained stable for the duration
of the experiment (20 minutes)[36]. The time 0 meas-
urement in that study was at a very similar state of an-
esthesia as our 4 and 5 minute time points (starting as
soon as possible and within 20 to 60 seconds of adequate
anesthesia), and the 5 minute rat time point was similar
to our 9 and 10 minute measurement times. Thus, al-
though both rat and mouse studies show that anesthesia
decreases IOP, the studies do not agree on the timing of
the effect. The IOP depression occurred very soon after
anesthesia in the rats but was delayed in the mice.
Environment may influence the effect of anesthesia
Factors that may influence the effect of anesthesia in-
clude the species, strain and environment used. Essen-
tially the same dose of ketamine and route of
administration was used in both the rat and mouse IOP
studies. In mice, the strain does not appear to be impor-
tant as no early effect of anesthesia was present in the
Figure 8
Myoc alleles do not associate with IOP.  Sequencing identified two alleles of Myoc in these mouse strains (see text).
Mouse strains homozygous for an allele having a 12 bp insertion in the promoter region are shown as open bars and strains
homozygous for the allele without this insertion have filled bars. The IOP data is the same as that in Figure 1.
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three distantly related laboratory strains [37] we studied
in detail, and we have not observed any obvious effect
during this period in any analyzed strain. Environmental
differences may be important. Cage cleanliness, chang-
ing frequency and housing density can alter drug metab-
olism and the effect of anesthesia in rats [38,39]. The
type of bedding used also may be important. We use
wood shavings for bedding and wood shavings expose
the mice to terpenes. Terpene administration or environ-
mental exposure to terpenes in wood shavings alters
drug resistance and decreases the effect of anesthetic
agents in both rats and mice [40–45].
Risk factors for increased IOP
Some epidemiological studies implicate factors such as
diabetes, vascular hypertension, arterial hypotension,
vasospasm, aberrant autoregulation of blood flow and
sex in glaucoma. Other studies find no association be-
tween these factors and glaucoma [2,46–48]. Similarly,
the effects of various factors including age, gender, blood
pressure, obesity and diabetes have been variably associ-
ated with elevated IOP. We evaluated the relationship
between these latter factors and IOP in genetically ho-
mogeneous mouse strains in a controlled environment.
Age
Although within the range of variability observed in
young mice, the IOP of B6 mice modestly decreased
around 1 year of age. This decrease was statistically sig-
nificant compared to young mice measured at the same
time. At 2 years of age the IOP of B6 mice had decreased
further, though an effect of anesthesia in these very old
mice cannot be ruled out [49]. The IOP of 129P3/J mice
also decreased with age but only at the oldest age exam-
ined (18 months). Decreasing IOP correlates with in-
creasing age in the human Japanese population [50,51].
Further studies of B6 mice may allow experimental in-
vestigation of this effect. Additional studies may also
identify " normal" mouse strains that develop increased
IOP with age as generally occurs in Western populations
Figure 9
Effects of genetic alterations.  Mean IOP ± SEM is shown. There is no difference in IOP between 3 to 4 month old males
with either the 129P2/Ola (n = 18) or C57BL/6J (n = 20) Y chromosome (Y Chr). The 129 Y Chr had been backcrossed to
strain C57BL/6J for 11 generations. Similarly, 6 to 9 month old males and females that are homozygous for normal (+) or
mutant (n) alleles of Car2 have similar IOPs (n = 18 and 14, respectively). However, 4 months old males homozygous for the
Lepr diabetes and obesity causing mutation (db) had significantly higher IOPs than their heterozygous age and sex matched lit-
termates. The average body weight of the homozygotes and heterozygotes was 59 g (range 50 to 64 g) and 35 g (range 28 to
41 g) respectively. Blood sugar levels in db /db males of this age are almost always in the diabetic range whereas those of heter-
ozygotes are not [27]. This was recently confirmed in cohorts of approximately 25 males of each genotype (mean ± SD; db/db
422 ± 110 mg/dl ; db/+ 147 ± 19 mg/dl; Anthony Nicholson, The Jackson Laboratory, personal communication)
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[52,53]. We previously demonstrated that the glaucoma-
tous strains DBA/2J and AKXD-28/Ty develop elevated
IOP with age [14,19].
Gender
In the examined strains, we found no consistent differ-
ences in IOP between males and females. This was true
at all ages for the 3 strains that were aged to 18 months
or older. This is in agreement with a number of human
studies, which show that IOP is equal between the sexes
[52,53]. However, some studies have found sex-specific
differences (typically with higher IOP in females and the
magnitude of the difference increasing after 40 years of
age) [53,54]. Of possible relevance, we previously report-
ed that female mice of strains DBA/2J and AKXD-28/Ty
develop elevated IOP at an earlier age than males [14,19].
Blood pressure
Some but not all human studies have reported a positive
association between IOP and blood pressure [48,52].
Our comparison of the relationship between blood pres-
sure and IOP in young, adult female mice of different
mouse strains, whose blood pressures differed up to 36
mmHg, did not reveal a positive correlation. Further
studies are needed to determine if blood pressure corre-
lates with IOP in males, and to determine the relation-
ship between blood pressure and IOP in various mouse
strains with age.
Obesity and diabetes
Obesity or higher body mass index have been implicated
by some but not other studies as risk factors for in-
creased IOP and glaucoma [51,55–57]. Similarly, diabe-
tes or the combination of diabetes and obesity have been
variably associated with elevated IOP and glaucoma
Figure 10
Tyr mutation results in increased IOP and altered diurnal changes  A. Different cohorts of C57BL/6J mice that are
homozygous for the spontaneous Tyr c-2J mutation have higher IOP than their normal counterparts at all tested ages. All groups
consisted of male and female mice. B. IOP is not increased during the dark period of the day in Tyr c-2J homozygotes. The
number of mice analyzed during the light period were: 2 month, 28 +/+, 29 c-2J/c-2J, 4 month, 20 +/+ and 20 c-2J/c-2J, 8
month, 15 +/+ and 15 c-2J/c-2J. Fourteen mice of each genotype were successfully analyzed during the dark period of the day.
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[46,52,58–62]. To test if genetic perturbations that
cause obesity and diabetes can alter IOP, we compared
groups of mice that were genetically similar except that
they were either homozygous or heterozygous for a leptin
receptor mutation (db) that results in early onset obesity
and diabetes. The obese, diabetic mice had higher IOPs
than their lean, non-diabetic littermates. Thus, epidemi-
ological associations between increased IOP and obesity
or diabetes are supported by this work and appear to be
functionally relevant. Further experiments with obese
non-diabetic or diabetic non-obese mice will help to
characterize the separate effects of these risk factors.
IOP is increased during the dark period of the day
Diurnal variation in IOP is common in humans and lab-
oratory animals [53]. The molecular mechanisms under-
lying the diurnal rhythm are not defined but increased
aqueous humor production or flow occurs during the pe-
riod of increased IOP in both rabbits and humans [63–
65]. Small changes in the resistance to aqueous humor
drainage may also contribute to diurnal differences in
IOP [66,67]. We first suspected IOP changes with time of
day when the IOP of a group of B6 mice measured in the
hour prior to onset of the dark period appeared to be
higher than at other times of day. Previously, a rise of
IOP was reported to occur before onset of the dark period
in rats [21], and rats and rabbits were shown to have
higher IOP during the dark period compared to the light
period [21,68,69]. Thus, we compared the IOPs of mice
at different times of day and identified several strains
with significantly higher IOP during the dark compared
to the light period. The magnitude of the difference var-
ies with strain, and was greatest in SWR/J. The IOP in-
crease in the dark is not dependent on functional rod and
cone photoreceptors since these cells degenerate in
SWR/J mice due to homozygosity for the Pde6b rd1 mu-
tation. In agreement with this finding, circadian regula-
tion of wheel running by light was previously reported in
mice lacking rods and cones [70]. Interestingly, the IOP
of strain CBA/CaJ, which has one of the highest daytime
IOPs does not appear to increase in the dark. Further
more detailed studies are needed to define the character-
istics of the diurnal rhythm of intraocular pressure in
mice, and to determine whether it is lacking or has a dif-
ferent timing in strain CBA/CaJ. Analysis of these mouse
strains may increase understanding of the molecular
mechanisms controlling diurnal rhythms of IOP and that
may be relevant to glaucoma.
Car2 deficiency does not alter IOP
Bicarbonate formation is important for aqueous humor
secretion from the ciliary processes and carbonic anhy-
drase (CA) facilitates this secretion. There are multiple
forms of CA and the CAII isoform is reported to be the
predominant form in the ciliary processes [71,72]. Our
experiments show that a genetic deficiency of CAII in
mice homozygous for a mutation in the Car2 gene does
not alter IOP. CAIV activity was recently demonstrated
in the ciliary processes [73] and so our data may support
a more substantial role for CAIV compared to CAII in
aqueous humor secretion. It also is possible that CAII
substantially contributes to aqueous humor secretion
but that functional mouse CAIV is sufficient to prevent
an effect of CAII deficiency on IOP in Car2 mutant mice.
In support of a role for both enzymes, a greater than 90%
inhibition of CA is required for significant reduction of
aqueous secretion [71,72].
Tyrosinase deficiency results in increased IOP
Tyrosinase is the first enzyme of the pigment production
pathway. Tyrosinase deficiency causes albinism and has
various ocular consequences. These include alteration of
the number of ipsilaterally projecting retinal axons and
substantially increased light penetration past the iris
[74]. It is not known if these abnormalities affect mam-
malian IOP. Here, we show increased IOP in mice lack-
ing tyrosinase activity compared to otherwise genetically
identical pigmented B6 mice. Additionally, IOP differ-
ences between the light and dark period of the day were
detected in the pigmented but not the albino B6 mice.
Thus, albinism can affect the diurnal pattern of IOP
changes. In agreement with this result, mice with albino
eyes that are homozygous for tyrosinase or pink eye dilu-
tion mutations have altered diurnal rhythms compared
to pigmented mice [75]. Albinism by itself is either not
sufficient to alter the diurnal rhythm of IOP or alters it in
different ways depending upon genetic background,
however, since the albino strains BALB/cByJ and SWR/
J had increased IOP during the dark. Diurnal rhythms
are known to depend on visual pathways and to respond
to light intensity. Exposing rats to 24 hours of low light
abrogates the diurnal fluctuation of IOP and results in
constantly elevated IOP [36]. Further experiments will
determine the nature of the diurnal rhythm of IOP in the
albino B6 mice and if its alteration or other mechanisms
result in IOP elevation.
Conclusions
A broad range of reproducible IOP differences exists be-
tween inbred mouse strains and a diurnal rhythm of IOP
exists in different strains. Various factors have been var-
iably associated with risk for increased IOP in humans.
Genetically uniform, mice can be used to study the ef-
fects of these risk factors on IOP. In trained hands, our
measurement procedure is reliable, accurate and rapid
enough to allow large scale genetic studies of factors de-
termining IOP. Mice have great potential for helping to
characterize the molecular mechanisms affecting IOP.BMC Genetics 2001, 2:12 http://www.biomedcentral.com/1471-2156/2/12
Materials and Methods
Animal husbandry
All experiments were performed in compliance with the
ARVO statement for use of animals in ophthalmic and vi-
sion research. All mice were bred and maintained at The
Jackson Laboratory. Mice were housed in cages contain-
ing white pine bedding and covered with polyester fil-
ters. For most experiments, the mice were fed NIH31 (6
% fat) chow ad libitum, and their water was acidified to
pH 2.8 to 3.2. B6 mice develop diet induced diabetes
when maintained on a high fat diet [76]. To ensure that
we were analyzing the effect of age and not diabetes, the
B6 mice in the aging experiment were fed NIH31 (4% fat)
chow. We have found no differences in IOP between B6
mice housed on the 4% fat and 6% fat versions of this
otherwise identical diet. The mice were group housed
and the cages were changed one time per week. If any
cage appeared soiled between scheduled changes, the
mice were placed in a clean cage. The environment was
kept at 21°C with a 14 hour light: 10 hour dark cycle. The
colony was monitored for specific pathogens by The
Jackson Laboratory's routine surveillance program (see
[http://www.jax.org]  for specific pathogens).
Intraocular pressure
Intraocular pressures were measured as described else-
where [13,77]. The mice were typically acclimatized to
the procedure room for at least 2 weeks prior to measure-
ment, but sometimes between 1 and 2 weeks. Although it
was not possible to include all strains in each measure-
ment period, mice of different strains were intermixed.
As demonstrated here, the IOPs of C57BL/6J are very
consistent over time and so these animals were inter-
spersed with experimental mice during all experiments
to ensure that calibration had not drifted and that the
system was functioning optimally. Whenever possible,
the investigator measuring IOP did not know the geno-
types of the animals. It was not possible to analyze all age
groups of each strain at the same time in the aging exper-
iments. Therefore, to control for potential IOP changes
due to measurement time and not age, approximately 3
month old B6 mice were assessed at the same time as
each age group. All dark period measurements were
made between 1 and 3 hours after the lights turned off.
The room was equipped with dim red lights and mice
were protected from all light exposure during set up.
Each mouse was briefly exposed to the red light when the
anesthetic agents were administered. When adequate
anesthesia was achieved (after 3 to 4 minutes), the
mouse was placed on the measurement platform and the
white light of the microscope was turned on (for approx-
imately 1 and a half minutes) to allow ocular cannulation,
IOP measurement and post-measurement tests [13] that
guard against artifactual data. The white light was used
at very low intensity and was dim but we cannot rule out
the possibility that this brief exposure altered the IOP.
All other mice were protected from light exposure
throughout the time an individual mouse was analyzed.
Blood pressure
The blood pressures of conscious mice of each strain (6
to 12 females per strain) were measured with a tail-cuff
system as reported [78], except that 5 days of training
were used. The mice were analyzed in the same proce-
dure room as was used for IOP measurment.
Clinical examinations
For most strains, anterior chambers were examined with
a slit lamp biomicroscope [16]. At least 8 mice of each
strain shown in figure 1 were evaluated. However, the an-
terior chambers of C57BLKS/J mice were only evaluated
under a dissection microscope at the time of IOP meas-
urement.
Histological analysis
Eyes from at least 2 mice of the listed strains were fixed
(4% paraformaldehyde or Fekete's acid-alcohol-formalin
fixative) processed, paraffin embedded and sectioned as
previously reported [15,79], except that the paraformal-
dehyde was buffered with 0.1 M phosphate buffer. All
strains other than CBA/CaHN and C57BLKS/J strains
were evaluated. The eyes of CBA/CaJ and BALB/cJ mice
were also fixed and processed for plastic embedding
(Historesin, Leica, Heidelberg, Germany), and sectioned
as previously reported [14,79]. Saggital sections includ-
ing the pupil and optic nerve were collected and analyzed
as they contain most ocular structures.
Analysis of Myoc
Exons and the proximal promoter of the mouse Myoc
gene were amplified from mouse genomic DNA using the
following combinations of primers:
Exon 1: 5'-cttgcaggagaactttccagaa-3' and 5'-atctcgaagga-
gattgttatagg-3'
5'-gaccagctggagacccaaaccag-3' and 5'-gctcagatccactgac-
ctaaa-3'
Exon 2: 5'-tgaagccatactttaccaaccat-3' and 5'-caaaaggga-
gaagtctaacttc-3'
Exon 3: 5'-agtcaaggctcacagagctaa-3' and 5'-aagagtagct-
gctcaccgtgtacaag-3'
5'-agacattgacttagctgtggat-3' and 5'-cggaacttcaccttttct-
ggc-3'
Promoter: 5'-taggagaagtctcattatactgc-3' and 5'-ttcact-
ggaccagcataagga-3'BMC Genetics 2001, 2:12 http://www.biomedcentral.com/1471-2156/2/12
5'-tctgaggatgttcacaggtttat-3' and 5'-tcttctggaaagttctcct-
gca-3'
Samples underwent 30 cycles of amplification with Per-
kin-Elmer Taq polymerase in a PTC Thermal Cycler (MJ
Research, MA) (94° for 40 sec, 57° for 1 min, 72° for 2
min). The PCR products we purified and sequenced as
described [22].
Abbreviations
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